FDA Import Refusal AEK-9268216-8/10003/1 — HBC Lifesciences Private Limited
The FDA refused shipment AEK-9268216-8/10003/1 from HBC Lifesciences Private Limited (India) on Jan 28, 2026. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Jan 28, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 118,75